event-trade登录编辑
🇺🇸 SECLantheus Holdings, Inc.Doubao · 实盘不做把握 8/10不做原因:风险收益比不佳
北京时间·🕒 发布 04:30:26·⟳ 抓取 04:31:04 +38s·⚡ 决策 10-15 04:35:06 +4m02s·12.6 天前

Lantheus股东高票批准Curium私有化合并,但属预定程序性进展

投票通过确实移除了股东批准条件,但该投票日期和提案早在9月8日最终委托书中明确,高票通过基本属于并购流程内的预期事件;LNTH现价100美元距102.50美元现金底价仅约2.5%,且仍有反垄断审查和交割时间风险,或有价值权最高12美元并非保底,短线追多的赔率不足。

📄 原文Lantheus Holdings, Inc.↗ 原文
----- d183496d8k.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REP…
不做 Lantheus Holdings, Inc.(LNTH.US)
不做并购套利追多:股东批准是已排期且高确定性的程序性事件,现价100美元距102.50美元现金底价仅约2.5%,HSR反垄断审查和交割时点仍构成实质风险,最高12美元CVR依赖里程碑而非保底;也无公司级利空支持做空。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

Lantheus股东正式批准Curium收购,是合并流程的正向里程碑;但该事件为预定程序、市场自8月起已有现金对价锚定,当前底价套利空间有限且监管风险未消,因此不开新仓。

🔎 新鲜度:最早出现 2026-10-14 · 扩散 low · price-in 风险 high ↗ ↗

消息传播链

  1. 2026-10-14 16:30 EDT官方披露SEC EDGAR 8-K Item 5.07一手源原文 ↗
    Lantheus在特别股东大会后通过8-K正式披露三项投票结果,合并协议以55,457,863股赞成获得批准;该文件是本次具体催化的一手披露。
    市场反应:可得行情截至美东16:15,LNTH报100美元、接近现金并购底价,早于16:30的8-K提交,不能作为披露后反应。

关键理由

  • 合并协议获55,457,863股赞成,股东批准这一交割条件已被移除。
  • 交易提供每股102.50美元现金底价及最高12美元或有价值权,相对100美元现价存在合同对价锚。

主要风险

  • 美国反垄断审查仍可能延迟或要求救济,2.5%的现金底价空间难以覆盖破局或延期风险。
  • 投票为预先公告的程序性事项,现金并购价格自8月3日起已长期可交易,次日继续向底价收敛的edge有限。

反向证据

  • 做多前查反向 · 来源 web · 日期 2026-09-21 · 影响 weakens
    SEC相关8-K和媒体摘要均指向HSR审查时间线延长/重启,交易尚未完全清除监管条件;该因素不否决合并,但显著降低2.5%底价价差的吸引力。
    检索:Lantheus Curium merger HSR renewed antitrust review September 2026 closing conditions 原文 ↗
  • 做多前查反向 · 来源 web · 日期 2026-10-02 · 影响 weakens
    投票会议、提案和委托材料在会前已公开,当前高票通过更像预定条件落地,而非新的报价或基本面上调。
    检索:Lantheus Curium shareholder vote expected proxy recommendation special meeting October 2026 原文 ↗

先例如何影响了这次决策

对本次决策的影响:先例不足与有限合同价差共同支持不追多,而非仅凭程序性批准开仓。

方向:未检索到足以作为交易级样本的、同市场同相位且能确认首发锚点的现金制药并购股东投票先例,不能把股东批准机械外推为正收益。

涨幅量级:缺乏高相似aligned样本来校准投票后1/3/5日涨幅;当前仅能用合同现金底价与现价的约2.5%差值作为上限参考。

形态:无法从已核验先例判断是否系统性高开低走;但本案价格长期贴近现金对价,符合并购套利而非事件驱动重估特征。

工具执行结果 · 成功 17 · 降级 0 · 失败 1 · 取消 0
  1. search_processed_events 成功 stock_tools HTTP · 11 ms
    {"result": "search_processed_events:agent query=`lantheus coco merger sub shareholder vote 55,457,863 | lantheus curium merger stockholder approval october 14 2026 | lnth special meeting merger agreement proposal approved curium `;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agen
  2. web_search 成功 doubao_search · 1,663 ms
    豆包搜索结果(原始查询:Lantheus Curium merger agreement August 3 2026 price per share conditions closing;API SearchType:web)
  3. web_search 成功 doubao_search · 2,570 ms
    豆包搜索结果(原始查询:Lantheus stockholders approve Curium merger October 14 2026 LNTH;API SearchType:web)
  4. stock_quote 成功 stock_tools HTTP · 1,245 ms
    {
  5. direct_instrument_candidates 成功 stock_tools HTTP · 8 ms
    {
  6. web_search 成功 doubao_search · 437 ms
    web_search「site:sec.gov/Archives/edgar/data/1521036 August 3 2026 Lantheus Curium "$100" per share merger」无结果。
  7. web_search 成功 doubao_search · 1,675 ms
    豆包搜索结果(原始查询:Curium Lantheus merger consideration per share cash $80 billion 2026 antitrust closing expected;API SearchType:web)
  8. web_search 成功 doubao_search · 1,314 ms
    豆包搜索结果(原始查询:LNTH merger arbitrage spread Curium 2026 October approval remaining regulatory conditions;API SearchType:web)
  9. search_case_library 成功 stock_tools HTTP · 15 ms
    {"result": "search_case_library「LNTH.US」—— 与这些标的相关的自家决策案例(本页 10 条,该标的全历史相关记录共 18 条;ENTER 只按该标的自己的腿统计):\n◆ LNTH.US:相关历史决策 18 条 · 其中该标的 ENTER 0 条(0.0%) · 我们从没在这只票上 ENTER 过\n【对所查标的真 ENTER 过的:0 条 —— 相关案例里没有该标的自己的 ENTER 腿】\n【最近 10 条其它决策(多为「不做」,用来看这票最近在被什么消息刷屏)】\n• 2026-08-14 UTC 不做 · 事件:Lantheus宣布FDA批准TA
  10. web_search 成功 doubao_search · 1,458 ms
    豆包搜索结果(原始查询:"Lantheus" "$102.50" Curium merger CVR;API SearchType:web)
  11. web_search 成功 doubao_search · 806 ms
    web_search「"Lantheus stockholders" "Curium" "October 14, 2026" approval」无结果。
  12. web_search 失败 doubao_search · 5,072 ms
    ConnectTimeout: web_search 失败:豆包搜索 ConnectTimeout: _ssl.c:993: The handshake operation timed out
  13. web_search 成功 doubao_search · 766 ms
    web_search「site:sec.gov/Archives/edgar/data/1521036/000119312526329622 "closing" "102.50" Lantheus Curium」无结果。
  14. web_search 成功 doubao_search · 763 ms
    web_search「site:curiumpharma.com/2026/08/03/curium-merge-lantheus "$102.50" "closing"」无结果。
  15. web_search 成功 doubao_search · 1,177 ms
    豆包搜索结果(原始查询:Lantheus Curium merger expected close fourth quarter 2026 regulatory approval HSR;API SearchType:web)
  16. web_search 成功 doubao_search · 489 ms
    web_search「site:sec.gov/Archives/edgar 8-K "Item 5.07" "Merger Agreement Proposal" biotech merger stockholders approved 2025」无结果。
  17. web_search 成功 doubao_search · 503 ms
    web_search「site:sec.gov/Archives/edgar 8-K "stockholders approved" "merger agreement" "2025" "$102.50" acquisition」无结果。
  18. web_search 成功 doubao_search · 1,388 ms
    豆包搜索结果(原始查询:2025 shareholders approve acquisition 8-K merger agreement proposal cash deal pharmaceuticals special meeting;API SearchType:web)

原文全文

展开原文 · 5,336 字
----- d183496d8k.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 14, 2026
LANTHEUS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-36569
35-2318913
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
201 Burlington Road
South Building
Bedford
,
Massachusetts
01730
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(978)
671-8001
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common stock, par value $0.01 per share
LNTH
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07
Submission of Matters to a Vote of Security Holders
A special meeting of stockholders (the “special meeting”) of Lantheus Holdings, Inc. (“Lantheus”) was held on October 14, 2026. A total of 57,184,503 shares of Lantheus common stock, out of a total of 65,299,875 shares of Lantheus common stock outstanding and entitled to vote as of the close of business on September 1, 2026 (the record date for the special meeting), were present virtually or represented by proxy. The special meeting was held for the purpose of considering and voting upon the following proposals, each as described in further detail in the definitive proxy statement for the special meeting that was filed with the Securities and Exchange Commission (the “SEC”) on September 8, 2026. There were no recorded broker
non-votes.
Proposal 1: Merger Agreement Proposal
Lantheus stockholders approved the adoption of the Agreement and Plan of Merger, dated as of August 3, 2026 (as it may be amended and supplemented from time to time, the “merger agreement”), by and among Lantheus, Curium US Holdings LLC, a Delaware limited liability company (“Parent”), and Coco Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, and on the terms and subject to the conditions thereof, Merger Sub will be merged with and into Lantheus (the “merger”), whereupon the separate existence of Merger Sub will cease and Lantheus will be the surviving corporation in the merger and a wholly owned subsidiary of Parent (the “merger agreement proposal”). The votes on the merger agreement proposal are set forth in the table below:
Votes For
Votes Against
Abstentions
55,457,863
1,563,807
162,833
Proposal 2: Advisory Compensation Proposal
Lantheus stockholders approved, on an advisory
(non-binding)
basis, the compensation that may be paid or become payable to the named executive officers of Lantheus in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the “advisory compensation proposal”). The votes on the advisory compensation proposal are set forth in the table below:
Votes For
Votes Against
Abstentions
49,098,355
7,849,138
237,009
Proposal 3: Adjournment Proposal
Lantheus stockholders voted on a proposal to approve any adjournment of the special meeting, if necessary or appropriate, for the purpose of soliciting additional proxies if there were not sufficient votes at the special meeting, to adopt the merger agreement proposal (the “adjournment proposal”). The votes on the adjournment proposal are set forth in the table below:
Votes For
Votes Against
Abstentions
52,776,720
4,201,962
205,821
Because there were sufficient votes at the time of the special meeting to approve the merger agreement and the advisory compensation proposal, a vote on the proposal to adjourn the special meeting, while approved, was not necessary.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LANTHEUS HOLDINGS, INC.
By:
/s/ Daniel M. Niedzwiecki
Name:
Daniel M. Niedzwiecki
Title:
Chief Administrative Officer and General Counsel
Date: October 14, 2026

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

  1. a25dd5e0a8 · 2026-10-15 04:35 · doubao / doubao-seed-evolving-latest-version · 策略包 2226518bfdee当前